Stock Market

EXAS Stock Earnings: Exact Sciences Beats EPS, Revenue Estimates

Exact Sciences (NASDAQ:EXAS) reported results for the first quarter of 2023.

  • Exact Sciences reported a loss per share of 42 cents. That is much better than the analyst estimate for a loss of 75 cents per share.
  • The company reported revenue of $602.45 million.
  • This represents 10.8% positive surprise against the analyst estimate of $543.46 million.
  • You can read the full Exact Sciences press release here.

On the date of publication, Sarah Smith did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

Sarah Smith is the Editor-in-Chief of

Articles You May Like

Jump In Before the Jump Up: 3 Speculative Stocks Ready for a Rally
3 Solar Stocks That Should Be on Every Investor’s Radar This Fall
Analyst Upgrades: 3 Stocks Have Wall Street Feeling Warm & Fuzzy
3 Climate Change Stocks to Profit From the Eco-Trends Boom
3 Sizzling Oil Stocks to Seize as Crude Nears the $100 Mark